The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
Abstract Following the most recent modification by the American Academy of Pediatrics, based on American studies on RSV epidemiology, the Italian Drug Agency (AIFA) decided to limit the total financial coverage of the palivizumab prescription by the National Health Service only to the < 29 wGA group...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2017-08-01
|
| coleção: | Italian Journal of Pediatrics |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13052-017-0390-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|